Carregant...
Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation
Type I (T1) diabetes is an autoimmune and metabolic disease associated with bone loss. Previous studies demonstrate that T1-diabetes decreases osteoblast activity and viability. Bisphosphonate therapy, commonly used to treat osteoporosis, is demonstrated to inhibit osteoclast activity as well as ost...
Guardat en:
| Publicat a: | J Cell Physiol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4724196/ https://ncbi.nlm.nih.gov/pubmed/25641511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.24929 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|